|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
189,880,000 |
Market
Cap: |
8.20(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$22.35 - $45.12 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
6,421,474 |
16,362,156 |
22,225,245 |
23,997,377 |
Total Sell Value |
$220,990,156 |
$557,271,091 |
$708,106,900 |
$769,897,993 |
Total People Sold |
7 |
9 |
9 |
10 |
Total Sell Transactions |
10 |
21 |
26 |
42 |
End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Homcy Charles J |
|
|
2025-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
1,216,674 |
|
- |
|
Valantine Hannah |
|
|
2025-06-26 |
4 |
S |
$44.03 |
$100,824 |
I/I |
(2,289) |
398 |
|
- |
|
Valantine Hannah |
|
|
2025-06-26 |
4 |
S |
$44.01 |
$106,504 |
D/D |
(2,418) |
7,465 |
|
- |
|
Mccormick Frank |
|
|
2025-06-24 |
4 |
AS |
$44.23 |
$4,422,800 |
I/I |
(100,000) |
879,979 |
|
1% |
|
Valantine Hannah |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
8,353 |
|
- |
|
Lo Andrew |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
54,688 |
|
- |
|
Dachille Douglas A. |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
6,589 |
|
- |
|
Homcy Charles J |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
1,236,674 |
|
- |
|
Momtazee James C |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
95,080 |
|
- |
|
Aguiar Eric |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
6,589 |
|
- |
|
Satvat Ali J. |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
165,993 |
|
- |
|
Ellis Andrea |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
18,589 |
|
- |
|
Hassan Fred |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
25,889 |
|
- |
|
Daniels Ronald J |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
16,991 |
|
- |
|
Mccormick Frank |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
83 |
|
- |
|
Cook Jennifer E. |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
13,741 |
|
- |
|
Scott Randal W |
|
|
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
11,589 |
|
- |
|
Valantine Hannah |
|
|
2025-06-10 |
4 |
AS |
$40.00 |
$171,680 |
D/D |
(4,292) |
1,764 |
|
12% |
|
Valantine Hannah |
|
|
2025-06-10 |
4 |
OE |
$16.75 |
$71,891 |
D/D |
4,292 |
6,056 |
|
- |
|
Kumar Neil |
Chief Executive Officer |
|
2025-05-20 |
4 |
AS |
$33.40 |
$2,504,978 |
I/I |
(75,000) |
4,798,447 |
|
33% |
|
Kumar Neil |
Chief Executive Officer |
|
2025-05-19 |
4 |
AS |
$33.32 |
$871,764 |
D/D |
(26,156) |
217,404 |
|
33% |
|
Apuli Maricel |
Chief Accounting Officer |
|
2025-05-16 |
4 |
D |
$33.84 |
$161,755 |
D/D |
(4,780) |
142,859 |
|
- |
|
Kumar Neil |
Chief Executive Officer |
|
2025-05-16 |
4 |
D |
$33.84 |
$1,111,779 |
D/D |
(32,854) |
243,560 |
|
- |
|
Kumar Neil |
Chief Executive Officer |
|
2025-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
64,696 |
276,414 |
|
- |
|
Trimarchi Thomas |
President and CFO |
|
2025-05-16 |
4 |
D |
$33.84 |
$721,367 |
D/D |
(21,317) |
501,988 |
|
- |
|
377 Records found
|
|
Page 1 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|